NIH-funded research R21 grant

Understanding how genetic factors affect the immune response in Lyme disease.

Official title: Mechanistic Studies of the Role of Genetic Factors in VlsE Antigenic Variation by the Lyme Disease Spirochete

Funded at Washington State University · NIH-11127102 · Data updated 2026-11-12

This study is looking at how the bacteria that causes Lyme disease can change its surface to hide from our immune system, focusing on a specific protein called VlsE, which could help us find new ways to treat Lyme disease.

More Lyme Disease research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionWashington State University
NIH-funded
Lab location1 site (Pullman, United States)
Project startJanuary 1, 2025
Project endDecember 31, 2026
Funding year2025
Award (this year)$191,250
NIH project number1R21AI182112-01A1
Project IDNIH-11127102 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Lyme disease, particularly those experiencing persistent symptoms.

Less likely to help

Patients who do not have Lyme disease or those who have already resolved their infection may not benefit from this research.

What this research studies

This research investigates how the Lyme disease-causing bacteria, Borrelia burgdorferi, changes its surface proteins to evade the immune system. By studying a specific protein called VlsE, the researchers aim to uncover the genetic mechanisms that allow these changes to occur. They will use advanced genetic techniques to introduce mutations and analyze how these affect the bacteria's ability to survive and cause persistent infections. This work could lead to better understanding and potential new treatments for Lyme disease.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for treating or preventing Lyme disease by targeting the mechanisms of immune evasion.

How similar studies have gone: Previous research has shown promise in understanding antigenic variation in other pathogens, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Washington State University
    Pullman, United States
    Active

Researchers

  • Principal investigator: Bankhead, Troy Michael — Washington State University
  • Study coordinator: Bankhead, Troy Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.